Live Imaging of Immunity to M. tuberculosis

结核分枝杆菌免疫实时成像

基本信息

  • 批准号:
    10326395
  • 负责人:
  • 金额:
    $ 10.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-01-06 至 2023-12-31
  • 项目状态:
    已结题

项目摘要

Project Summary Tuberculosis (TB), caused by the bacterium, Mycobacterium tuberculosis, kills more humans every year than does any other infectious disease, including HIV. Among the obstacles to eliminating TB is the lack of a sufficiently-efficacious vaccine. Despite strong evidence for essential roles of CD4 T cells in TB immunity, naturally-occurring T cell responses do not reliably eliminate the pathogen in TB, and we do not fully understand the mechanisms that limit the effectiveness of CD4 T cell responses to M. tuberculosis. In earlier work, we discovered that for optimal immune control, CD4 T cells must directly recognize and make intermolecular contacts with M. tuberculosis-infected cells at the site of infection in the lungs. In light of this requirement for intimate contact, we and others have found (in mice, nonhuman primates, and humans) that CD4 T cells are located at the periphery of granulomas, rather than in the core where infected cells reside. We therefore hypothesize that a major mechanism limiting immunity to TB is the failure of CD4 T cells to contact and engage with infected cells, and that overcoming this failure will increase the efficacy of T cell immunity to TB. Several potential mechanisms can explain the spatial separation of M. tuberculosis-infected cells and CD4 T cells in vivo, yet these are not amenable to analysis using fixed, static images or cells removed from the granuloma environment. Therefore, in this project, we propose to combine a unique multiphoton microscopy system for intravital imaging, contained in a Biosafety Level 3 facility at the IPBS in Toulouse, with unique reporter mice and M. tuberculosis strains developed and characterized at UCSF, to characterize interactions of antigen-specific CD4 T cells with M. tuberculosis-infected and bystander cells in the lungs of live mice. The combination of these innovative experimental systems allows us to test specific hypotheses that can account for the spatial and functional separation of CD4 T cells and M. tuberculosis-infected cells in the lungs. The knowledge gained from these studies will be used: 1) to inform design of experiments to define the molecular mechanisms that restrict CD4 T cell interactions with M. tuberculosis-infected cells in vivo; 2) to provide the basis for studies comparing distinct candidate TB vaccines, to determine which of them promote development of T cells that optimally access M. tuberculosis-infected cells in granuloma cores. In additional experiments, we will extend recent findings indicating important roles for innate lymphoid cells (ILC) in protective immunity to TB. Specifically, we will follow up on findings that type 2 ILC (ILC2) undergo dramatic phenotypic transformations to ILC1-like cells in vivo in response to M. tuberculosis infection, by live imaging of the interactions of ILC2 and ILC1-like cells with M. tuberculosis-infected cells and with CD4 T cells, during the initial and the chronic stages of infection. Our studies have high potential to provide valuable insights and new paradigms of immunity to TB, with the goal of informing development of efficacious vaccines and host-directed therapies.
项目摘要 由结核分枝杆菌引起的结核病每年导致的死亡人数比 有没有其他传染病,包括艾滋病毒。消除结核病的障碍之一是缺乏 足够有效的疫苗。尽管有强有力的证据表明CD4T细胞在结核病免疫中起着重要作用, 自然产生的T细胞反应并不能可靠地消除结核病中的病原体,我们也不完全了解 限制CD4T细胞对结核分枝杆菌应答有效性的机制。在早期的工作中,我们 发现为了最佳的免疫控制,CD4T细胞必须直接识别和制造分子间 在肺部感染部位与结核分枝杆菌感染细胞接触。根据这一要求, 亲密接触,我们和其他人发现(在小鼠、非人类灵长类动物和人类中)CD4T细胞是 位于肉芽肿的边缘,而不是位于感染细胞所在的核心。因此,我们 假设限制对结核病免疫的一个主要机制是CD4T细胞无法接触和接触 通过感染细胞,克服这一缺陷将提高T细胞对结核病的免疫效力。几个 可能的机制可以解释体内结核分枝杆菌感染细胞和CD4T细胞的空间分离, 然而,这些不能用固定的静态图像或从肉芽肿中取出的细胞来分析 环境。因此,在这个项目中,我们建议结合一个独特的多光子显微镜系统来 活体成像,包含在图卢兹IPBS的生物安全3级设施中,使用独特的报告小鼠和 在加州大学旧金山分校培养和鉴定结核分枝杆菌菌株,以表征抗原特异性的相互作用 活体小鼠肺中带有结核分枝杆菌感染和旁观者细胞的CD4T细胞。这些结合在一起 创新的实验系统使我们能够测试特定的假设,这些假设可以解释空间和 肺中CD4T细胞和结核分枝杆菌感染细胞的功能分离。从以下方面获得的知识 这些研究将用于:1)为实验设计提供信息,以确定限制 体内CD4T细胞与结核分枝杆菌感染细胞的相互作用;2)为比较研究提供基础 不同的候选结核病疫苗,以确定其中哪种疫苗促进T细胞的发展,获得最佳的 肉芽肿核心内结核分枝杆菌感染细胞。在其他实验中,我们将扩展最新的发现 提示先天淋巴样细胞(ILC)在结核病保护性免疫中的重要作用。具体地说,我们将遵循 研究发现,2型ILC(ILC2)在体内经历了戏剧性的表型转化为ILC1样细胞。 对结核分枝杆菌感染的反应,通过实时成像ILC2和ILC1样细胞与结核杆菌的相互作用。 在感染的初始阶段和慢性阶段,结核感染细胞和CD4T细胞。我们的研究 有很高的潜力提供有价值的见解和结核病免疫的新范例,目的是向 开发有效的疫苗和宿主导向疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joel D. Ernst其他文献

The immunological life cycle of tuberculosis
结核病的免疫生命周期
  • DOI:
    10.1038/nri3259
  • 发表时间:
    2012-07-13
  • 期刊:
  • 影响因子:
    60.900
  • 作者:
    Joel D. Ernst
  • 通讯作者:
    Joel D. Ernst
Transfer of phagocytosed particles to the parasitophorous vacuole of Leishmania mexicana is a transient phenomenon preceding the acquisition of annexin I by the phagosome.
吞噬颗粒向墨西哥利什曼原虫寄生液泡的转移是吞噬体获得膜联蛋白 I 之前的短暂现象。
  • DOI:
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Helen L. Collins;Ulrich E. Schaible;Joel D. Ernst;David G. Russell
  • 通讯作者:
    David G. Russell
Editorial response: variation in clinical and immune responses to bacille Calmette-Guérin--implications for an improved tuberculosis vaccine.
编辑回应:卡介苗临床和免疫反应的变化——对改进结核病疫苗的影响。
Antibody-Fab and -Fc features promote emMycobacterium tuberculosis/em restriction
抗体的 Fab 和 Fc 特征促进了对结核分枝杆菌的限制。
  • DOI:
    10.1016/j.immuni.2025.05.004
  • 发表时间:
    2025-06-10
  • 期刊:
  • 影响因子:
    26.300
  • 作者:
    Patricia S. Grace;Joshua M. Peters;Jaimie Sixsmith;Richard Lu;Edward B. Irvine;Corinne Luedeman;Brooke A. Fenderson;Andrew Vickers;Matthew D. Slein;Tanya McKitrick;Mo-Hui Wei;Richard D. Cummings;Aaron Wallace;Lisa A. Cavacini;Alok Choudhary;Megan K. Proulx;Christopher Sundling;Gunilla Källenius;Rajko Reljic;Joel D. Ernst;Galit Alter
  • 通讯作者:
    Galit Alter
Finding and filling the knowledge gaps in mechanisms of T cell-mediated TB immunity to inform vaccine design
寻找并填补 T 细胞介导的结核病免疫机制中的知识空白,为疫苗设计提供信息
  • DOI:
    10.1038/s41577-025-01192-z
  • 发表时间:
    2025-06-13
  • 期刊:
  • 影响因子:
    60.900
  • 作者:
    Emma Lefrançais;Denis Hudrisier;Olivier Neyrolles;Samuel M. Behar;Joel D. Ernst
  • 通讯作者:
    Joel D. Ernst

Joel D. Ernst的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joel D. Ernst', 18)}}的其他基金

Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 10.1万
  • 项目类别:
Functional dynamics of TB granuloma architecture
结核肉芽肿结构的功能动力学
  • 批准号:
    10593978
  • 财政年份:
    2022
  • 资助金额:
    $ 10.1万
  • 项目类别:
Functional dynamics of TB granuloma architecture
结核肉芽肿结构的功能动力学
  • 批准号:
    10358264
  • 财政年份:
    2022
  • 资助金额:
    $ 10.1万
  • 项目类别:
Host genetic diversity, mononuclear phagocytes, and outcomes of TB
宿主遗传多样性、单核吞噬细胞和结核病的结果
  • 批准号:
    10005738
  • 财政年份:
    2020
  • 资助金额:
    $ 10.1万
  • 项目类别:
Host genetic diversity, mononuclear phagocytes, and outcomes of TB
宿主遗传多样性、单核吞噬细胞和结核病的结果
  • 批准号:
    10194362
  • 财政年份:
    2020
  • 资助金额:
    $ 10.1万
  • 项目类别:
Antigen export in M. tuberculosis evasion of CD4 T cells
结核分枝杆菌逃避 CD4 T 细胞的抗原输出
  • 批准号:
    9318402
  • 财政年份:
    2016
  • 资助金额:
    $ 10.1万
  • 项目类别:
Epitope-specific T cell activation to complement TB immunity and vaccine efficacy
表位特异性 T 细胞激活可补充结核病免疫和疫苗功效
  • 批准号:
    8867688
  • 财政年份:
    2014
  • 资助金额:
    $ 10.1万
  • 项目类别:
Initiation of the Immune Response to M. tuberculosis
对结核分枝杆菌的免疫反应的启动
  • 批准号:
    8678398
  • 财政年份:
    2014
  • 资助金额:
    $ 10.1万
  • 项目类别:
Mycobacterium tuberculosis evasion of CD4+ T cells in vivo
体内结核分枝杆菌逃避 CD4 T 细胞
  • 批准号:
    8678383
  • 财政年份:
    2013
  • 资助金额:
    $ 10.1万
  • 项目类别:
Training Program in Immunology and Inflammation
免疫学和炎症培训计划
  • 批准号:
    8495260
  • 财政年份:
    2012
  • 资助金额:
    $ 10.1万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Synthesis of complex carbohydrate antigens of pathogenic bacteria
病原菌复合糖抗原的合成
  • 批准号:
    RGPIN-2015-05756
  • 财政年份:
    2021
  • 资助金额:
    $ 10.1万
  • 项目类别:
    Discovery Grants Program - Individual
Synthesis of complex carbohydrate antigens of pathogenic bacteria
病原菌复合糖抗原的合成
  • 批准号:
    RGPIN-2015-05756
  • 财政年份:
    2020
  • 资助金额:
    $ 10.1万
  • 项目类别:
    Discovery Grants Program - Individual
Synthesis of complex carbohydrate antigens of pathogenic bacteria
病原菌复合糖抗原的合成
  • 批准号:
    RGPIN-2015-05756
  • 财政年份:
    2019
  • 资助金额:
    $ 10.1万
  • 项目类别:
    Discovery Grants Program - Individual
Synthesis of complex carbohydrate antigens of pathogenic bacteria
病原菌复合糖抗原的合成
  • 批准号:
    RGPIN-2015-05756
  • 财政年份:
    2018
  • 资助金额:
    $ 10.1万
  • 项目类别:
    Discovery Grants Program - Individual
Synthesis of complex carbohydrate antigens of pathogenic bacteria
病原菌复合糖抗原的合成
  • 批准号:
    RGPIN-2015-05756
  • 财政年份:
    2017
  • 资助金额:
    $ 10.1万
  • 项目类别:
    Discovery Grants Program - Individual
Synthesis of complex carbohydrate antigens of pathogenic bacteria
病原菌复合糖抗原的合成
  • 批准号:
    RGPIN-2015-05756
  • 财政年份:
    2016
  • 资助金额:
    $ 10.1万
  • 项目类别:
    Discovery Grants Program - Individual
Synthesis of complex carbohydrate antigens of pathogenic bacteria
病原菌复合糖抗原的合成
  • 批准号:
    RGPIN-2015-05756
  • 财政年份:
    2015
  • 资助金额:
    $ 10.1万
  • 项目类别:
    Discovery Grants Program - Individual
Epidemiological study of serum titers against V-antigens of gram-negative bacteria
革兰阴性菌V抗原血清滴度的流行病学研究
  • 批准号:
    24390403
  • 财政年份:
    2012
  • 资助金额:
    $ 10.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The structure and biosynthesis of glycopeptidolipid antigens from non-tureculous acid-fast bacteria, and their host responses
非结构性抗酸细菌糖肽脂抗原的结构和生物合成及其宿主反应
  • 批准号:
    22590399
  • 财政年份:
    2010
  • 资助金额:
    $ 10.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
display of synthetic antigens on intestinal bacteria based on chemicalbiology and their applications for mucosal vaccines
基于化学生物学的肠道细菌合成抗原展示及其在粘膜疫苗中的应用
  • 批准号:
    21350090
  • 财政年份:
    2009
  • 资助金额:
    $ 10.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了